About this trial
This randomized controlled trial investigates the effects of two types of stair-climbing exercise snacks versus moderate-intensity continuous training on vascular health, body composition, and blood lipids in overweight or obese adults. Participants will be assigned to one of four groups for 6-8 weeks. The control group receives no exercise intervention. Primary outcomes include endothelial function (ultrasound), body composition (InBody), and lipid profile (blood test).
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Age: 18-35 years old (male, female);
Clear consciousness, stable vital signs;
Able to understand and follow simple instructions;
No regular exercise for at least 3 months;
Disqualifiers
There are other serious diseases, such as tumors;
There are other neurological diseases;
There are serious diseases that simultaneously affect the heart, liver, kidneys, endocrine system or hematopoietic system;
There is a history of alcohol or drug abuse;
Trial design
Parallel
Treatments tested in this trial
Short-term stair climbing exercise snack group
BehavioralAdopt a fragmented approach, climbing stairs 4-5 times a day, each time climbing 5 floors (approximately 1 minute per session), with at least 1 hour of interval between each session, and spread throughout the daily activity periods. Exercise 3-5 days per week for a total of 6-8 weeks.
Long-duration stair climbing exercise snack group
BehavioralOn the basis of climbing stairs 4 to 5 times a day, increase the single exercise volume: complete 2 or 3 sets of climbing 5 floors of stairs each time (that is, the total number of floors climbed each time is 10 or 15), with no more than 1 minute of rest between sets. The intervals between each exercise should be at least 1 hour. Exercise 3 to 5 days a week, for a total of 6 to 8 weeks of intervention.
Moderate-intensity continuous exercise(MICT)
BehavioralExercise 3 to 5 days per week for a total of 6 to 8 weeks. Perform 30 minutes of moderate-intensity running training every day.
Treatment groups
Trial outcomes
Primary outcomes
Flow-mediated dilation (FMD, relative percentage)
Flow-mediated dilation expressed as a percentage of the baseline brachial artery diameter.Unit of Measure: %
Body fat mass
Body fat mass measured by bioelectrical impedance analysis (InBody device). Unit of Measure: kg
Time to peak dilation
Time required to reach maximal dilation after cuff deflation.Unit of Measure: seconds
Basal brachial artery diameter
Baseline diameter of the brachial artery before cuff inflation.Unit of Measure: mm
Secondary outcomes
Systolic blood pressure (SBP)
Systolic blood pressure measured using an electronic sphygmomanometer.Unit of Measure: mmHg
Serum high-density lipoprotein (HDL) cholesterol concentration
Fasting serum HDL cholesterol concentration measured from blood samples. Unit of Measure: mmol/L
Diastolic blood pressure (DBP)
Diastolic blood pressure measured using an electronic sphygmomanometer. Unit of Measure: mmHg
Heart rate
Heart rate measured using an electronic sphygmomanometer.Unit of Measure: bpm (beats per minute)
Locations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options: